ATE214056T1 - Benzodiazepinderivate - Google Patents
BenzodiazepinderivateInfo
- Publication number
- ATE214056T1 ATE214056T1 AT95902983T AT95902983T ATE214056T1 AT E214056 T1 ATE214056 T1 AT E214056T1 AT 95902983 T AT95902983 T AT 95902983T AT 95902983 T AT95902983 T AT 95902983T AT E214056 T1 ATE214056 T1 AT E214056T1
- Authority
- AT
- Austria
- Prior art keywords
- receptors
- optionally substituted
- cck
- lower alkyl
- conh
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33616893 | 1993-12-28 | ||
| PCT/JP1994/002132 WO1995018110A1 (fr) | 1993-12-28 | 1994-12-19 | Nouveau derive de benzodiazepine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214056T1 true ATE214056T1 (de) | 2002-03-15 |
Family
ID=18296379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95902983T ATE214056T1 (de) | 1993-12-28 | 1994-12-19 | Benzodiazepinderivate |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5776929A (de) |
| EP (1) | EP0728748B1 (de) |
| JP (1) | JP3621416B2 (de) |
| CN (1) | CN1073089C (de) |
| AT (1) | ATE214056T1 (de) |
| AU (1) | AU684871B2 (de) |
| CA (1) | CA2177960A1 (de) |
| DE (1) | DE69430068T2 (de) |
| ES (1) | ES2173167T3 (de) |
| PT (1) | PT728748E (de) |
| TW (1) | TW334428B (de) |
| WO (1) | WO1995018110A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691331A (en) * | 1995-06-07 | 1997-11-25 | Merck & Co., Inc. | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides |
| US6239131B1 (en) * | 1996-12-10 | 2001-05-29 | Zeria Pharmaceutical Co., Ltd. | 1,5 Benzodiazepine derivatives |
| JP2000026434A (ja) | 1998-06-05 | 2000-01-25 | Zeria Pharmaceut Co Ltd | 新規１，５−ベンゾジアゼピン誘導体 |
| GB0008179D0 (en) * | 2000-04-05 | 2000-05-24 | Glaxo Group Ltd | Chemical process |
| AU776283B2 (en) | 1999-12-02 | 2004-09-02 | Zeria Pharmaceutical Co., Ltd. | Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
| EP2065046B1 (de) * | 2007-11-30 | 2013-07-31 | Kao Corporation | GIP-Sekretionshemmer |
| JP5075254B2 (ja) | 2011-01-07 | 2012-11-21 | スノーデン株式会社 | 胃酸及びガストリンの産生を抑制する乳酸菌 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5408646A (en) * | 1991-03-29 | 1995-04-18 | International Business Machines Corp. | Multipath torus switching apparatus |
| DE69319945T2 (de) * | 1992-01-21 | 1999-03-11 | Glaxo Wellcome Spa | 1,5-Benzodiazepinderivate und deren Verwendung in Heilmittel |
| GB9201181D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Spa | Chemical compounds |
| AU688316B2 (en) * | 1993-04-15 | 1998-03-12 | Glaxo Wellcome Inc. | 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
| GB9307833D0 (en) * | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
| GB9308421D0 (en) * | 1993-04-23 | 1993-06-09 | Glaxo Spa | Chemical compounds |
-
1994
- 1994-12-19 DE DE69430068T patent/DE69430068T2/de not_active Expired - Fee Related
- 1994-12-19 US US08/663,304 patent/US5776929A/en not_active Expired - Fee Related
- 1994-12-19 CN CN94195039A patent/CN1073089C/zh not_active Expired - Fee Related
- 1994-12-19 AU AU12011/95A patent/AU684871B2/en not_active Ceased
- 1994-12-19 PT PT95902983T patent/PT728748E/pt unknown
- 1994-12-19 AT AT95902983T patent/ATE214056T1/de not_active IP Right Cessation
- 1994-12-19 EP EP95902983A patent/EP0728748B1/de not_active Expired - Lifetime
- 1994-12-19 WO PCT/JP1994/002132 patent/WO1995018110A1/ja active IP Right Grant
- 1994-12-19 JP JP51788795A patent/JP3621416B2/ja not_active Expired - Fee Related
- 1994-12-19 CA CA002177960A patent/CA2177960A1/en not_active Abandoned
- 1994-12-19 ES ES95902983T patent/ES2173167T3/es not_active Expired - Lifetime
- 1994-12-23 TW TW083112110A patent/TW334428B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69430068T2 (de) | 2002-08-14 |
| EP0728748A4 (de) | 1997-03-19 |
| CN1073089C (zh) | 2001-10-17 |
| TW334428B (en) | 1998-06-21 |
| CA2177960A1 (en) | 1995-07-06 |
| DE69430068D1 (de) | 2002-04-11 |
| PT728748E (pt) | 2002-06-28 |
| WO1995018110A1 (fr) | 1995-07-06 |
| EP0728748A1 (de) | 1996-08-28 |
| JP3621416B2 (ja) | 2005-02-16 |
| US5776929A (en) | 1998-07-07 |
| AU684871B2 (en) | 1998-01-08 |
| EP0728748B1 (de) | 2002-03-06 |
| CN1143362A (zh) | 1997-02-19 |
| AU1201195A (en) | 1995-07-17 |
| ES2173167T3 (es) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9301602D0 (en) | Angiotensine 11 antagonists | |
| KR940004391B1 (en) | Cyclic amide derivatives | |
| ES2134835T3 (es) | Derivados de piperazina como antagonistas de los receptores 5-ht. | |
| ATE214056T1 (de) | Benzodiazepinderivate | |
| DE59706686D1 (de) | Kondensierte 2,3-benzodiazepin derivate und deren verwendung als ampa-rezeptoren-hemmer | |
| ATE212356T1 (de) | Carbamoylmethylharnstoffderivate | |
| DE59206593D1 (de) | Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe | |
| ATE505463T1 (de) | Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten | |
| ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. | |
| PT100855A (pt) | Utilizacao de um composto heterociclico biciclico, em especial um derivado de benzodioxano, para a preparacao de um medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |